Anneline S. J. M. Te Riele

Dr. Anneline S. J. M. Te Riele


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2013 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
ARAnneline S. J. M. Te Riele
Anneline S. J. M. Te Riele
CJCynthia A. James
Cynthia A. James
BPBinu Philips
Binu Philips
NRNeda Rastegar
Neda Rastegar
ABAditya Bhonsale
Aditya Bhonsale
HTHarikrishna Tandri
Harikrishna Tandri

1 April 2014 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
BPBinu Philips
Binu Philips
SMSrinivasa Madhavan
Srinivasa Madhavan
CJCynthia A. James
Cynthia A. James
ARAnneline S. J. M. Te Riele
Anneline S. J. M. Te Riele
BMBrittney Murray
Brittney Murray
ACAlan Cheng
Alan Cheng
Background—: Cardiac sarcoidosis (CS) may show overlap in the clinical presentation with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). We sought to investigate patients with CS who were misdiagnosed with ARVD/C and identify clinical features to distinguish these 2 groups. Methods and Results—: Among patients enrolled in the Johns Hopkins ARVD/C registry, 15 patients with definite 2010 diagnostic criteria for ARVD/C were subsequently diagnosed with CS. Forty-two pathogenic desmosomal mutation carriers with definite ARVD/C based on the 2010 diagnostic criteria served as a control group. Patients with CS were older at the age of symptom onset, more likely to have comorbidities, and develop heart failure symptoms over time ( P <0.05). Electrocardiographically, PR interval prolongation and high-grade atrioventricular block were exclusively associated with CS ( P <0.05). HV interval prolongation and increased number of ventricular tachycardias induced were also associated with CS ( P <0.05). Radiographically, significant left ventricular dysfunction, myocardial delayed enhancement of the septum, and mediastinal lymphadenopathy were more often see in those with CS ( P <0.05). Conclusions—: The 2010 diagnostic criteria for ARVD/C have limited discrimination in distinguishing between ARVD/C and CS. Despite the overlay in clinical presentation, older age of symptom onset, presence of cardiovascular comorbidities, nonfamilial pattern of disease, PR interval prolongation, high-grade atrioventricular block, significant left ventricular dysfunction, myocardial delayed enhancement of the septum, and mediastinal lymphadenopathy should raise the suspicion for CS.

1 November 2013 in JACC
Verified
Journal Article
Closed access
ARAnneline S. J. M. Te Riele
Anneline S. J. M. Te Riele
ABAditya Bhonsale
Aditya Bhonsale
CJCynthia A. James
Cynthia A. James
NRNeda Rastegar
Neda Rastegar
BMBrittney Murray
Brittney Murray
HTHarikrishna Tandri
Harikrishna Tandri

1 January 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
PDF file
JCJulia Cadrin-Tourigny
Julia Cadrin-Tourigny
LBLaurens P. Bosman
Laurens P. Bosman
WWWeijia Wang
Weijia Wang
RTRafik Tadros
Rafik Tadros
ABAditya Bhonsale
Aditya Bhonsale
CJCynthia A. James
Cynthia A. James
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with ventricular arrhythmias (VA) and sudden cardiac death (SCD). A model was recently developed to predict incident sustained VA in patients with ARVC. However, since this outcome may overestimate the risk for SCD, we aimed to specifically predict life-threatening VA (LTVA) as a closer surrogate for SCD. Methods: We assembled a retrospective cohort of definite ARVC cases from 15 centers in North America and Europe. Association of 8 prespecified clinical predictors with LTVA (SCD, aborted SCD, sustained, or implantable cardioverter-defibrillator treated ventricular tachycardia >250 beats per minute) in follow-up was assessed by Cox regression with backward selection. Candidate variables included age, sex, prior sustained VA (≥30s, hemodynamically unstable, or implantable cardioverter-defibrillator treated ventricular tachycardia; or aborted SCD), syncope, 24-hour premature ventricular complexes count, the number of anterior and inferior leads with T-wave inversion, left and right ventricular ejection fraction. The resulting model was internally validated using bootstrapping. Results: A total of 864 patients with definite ARVC (40±16 years; 53% male) were included. Over 5.75 years (interquartile range, 2.77–10.58) of follow-up, 93 (10.8%) patients experienced LTVA including 15 with SCD/aborted SCD (1.7%). Of the 8 prespecified clinical predictors, only 4 (younger age, male sex, premature ventricular complex count, and number of leads with T-wave inversion) were associated with LTVA. Notably, prior sustained VA did not predict subsequent LTVA ( P =0.850). A model including only these 4 predictors had an optimism-corrected C-index of 0.74 (95% CI, 0.69–0.80) and calibration slope of 0.95 (95% CI, 0.94–0.98) indicating minimal over-optimism. Conclusions: LTVA events in patients with ARVC can be predicted by a novel simple prediction model using only 4 clinical predictors. Prior sustained VA and the extent of functional heart disease are not associated with subsequent LTVA events.

1 July 2018 in Heart Rhythm
Verified
Journal Article
Closed access
LBLaurens P. Bosman
Laurens P. Bosman
ASArjan Sammani
Arjan Sammani
CJCynthia A. James
Cynthia A. James
JCJulia Cadrin-Tourigny
Julia Cadrin-Tourigny
HCHugh Calkins
Hugh Calkins
ARAnneline S. J. M. Te Riele
Anneline S. J. M. Te Riele

1 September 2012 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
ATArco J. Teske
Arco J. Teske
MCMoniek G.P.J. Cox
Moniek G.P.J. Cox
ARAnneline S. J. M. Te Riele
Anneline S. J. M. Te Riele
BBBart W. De Boeck
Bart W. De Boeck
PDPieter A. Doevendans
Pieter A. Doevendans
MCMaarten J.M. Cramer
Maarten J.M. Cramer